Study Shows COVID-19 Patients Receiving Hydroxychloroquine See Death Rates Cut in Half

Hydroxychloroquine LifeNews Press The Daily Signal

Study Shows COVID-19 Patients Receiving Hydroxychloroquine See Death Rates Cut in Half

Early in health officials’ response to the pandemic, one drug offered hope of a safe, widely available, and cheap therapeutic that would break the death grip that COVID-19 held on the world. However, after its promised efficacy didn’t materialize in large, statistically significant numbers, enthusiasm for the drug, hydroxychloroquine, quickly waned.